Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

Old API Wind-down Ltd - Ordinary Shares > Its going to get ugly-
View:
Post by Bigboyone on Mar 15, 2016 3:33pm

Its going to get ugly-

I am very surprised that the merge of Tribute and Pozen, which is, the sum of Aralez parts.. are now worth less then when Pozen was on its own.
This is a low Pozen has not seen for 10 + years.
We have a new trading range fella's,$4.50-$5.20 and I wouldnt be surprised if we broke $4.00 on the downside in next few days.
Fundamentals have not changed, but the fund guys follow each other and I am afraid they may all now cut loose. (Truth be told, why hold money here?)
I do feel they will come back in at somepoint, but who knows when that will be. 
Sadly, as all of us who owned Tribute, feel shafted as I though we should have recieved .24, not .14..but too late now, as I have to watch my other 2014-2015  stock picks 50%+ higher or double, etc...and  think what could have been with my $.-
Comment by select1011 on Mar 15, 2016 3:40pm
This post has been removed in accordance with Community Policy
Comment by snootchybootchy on Mar 15, 2016 3:57pm
I think some of this selling can be attributed to the Valeant debacle.  I think people will buy back into healthcare once Valeant finds a bottom.  I wouldn't be surprised if there is a bounce tomorrow as both Valeant and Aralez look extremely oversold.
Comment by select1011 on Mar 15, 2016 4:32pm
This post has been removed in accordance with Community Policy
Comment by Bigboyone on Mar 15, 2016 4:46pm
100% agree..Dead on- Tribute shareholders where railroaded and Harris, et Al: cashed out..end of story. We all had the chance to get out...but bought in to the fact that we where going higher.. I do think, Adams has a plan, but its not going to happen now, sorry to say it may not even be in 2016, We will surely know when something good is going on, the price to watch is about upper $6- $7 or so ...more  
Comment by kuatolives on Mar 15, 2016 5:22pm
Who knows, yospral might get approved, a few deals get signed, by this time next year the stock could be at 20 bucks. Nobody knows.  Concordia lost more than 8% today on no news so what can you do. Buy more, sell, or hold. That about covers it eh.
Comment by surfingthebeach on Mar 15, 2016 10:57pm
Agreed - this is still a very new company with a little bit of old baggage.  I am glad they are spending money on a large experienced sales force.  Also good they are looking at purging unprofitable drugs and looking to buy or merge with companies that are a good fit along with looking for good drugs to add when available.  Again, licensing existing holdings in other countries ...more  
Comment by Bigboyone on Mar 24, 2016 2:56pm
Kuato- Glad your optimistic, I am not so much, so , I would say I am hopeful, As everytime, we test a new 52 week low, its like a punch in the stomach. I would guess on performance.. its still going to get worse before its gets better.  Our Tribute shares are A-kin to a revese split , which anyone in the biz knows that usually a kiss of death..
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities